Thermo Fisher Scientific Expands Oral Solid Dose Development and Manufacturing Capabilities Across North America Read more
Acumen Pharmaceuticals Extends Collaboration with Lonza to Add Drug Product Manufacturing of Sabirnetug for Early Alzheimer’s Disease Read more
Boehringer Ingelheim partners with NCD Alliance to target Non-Communicable Diseases in underserved communities Read more
Phare Bio Secures Up to $27 Million from ARPA-H to Propel AI-Driven Drug Discovery and Innovate New Antibiotics Read more
Tempus Expands Partnership with Takeda to Enhance Oncology Research Using Multimodal Real-World Data and Biological Models Read more
Tagrisso approved in the US for patients with unresectable, Stage III EGFR-mutated lung cancer Read more
Pfizer Voluntarily Withdraws All Lots of Sickle Cell Disease Treatment OXBRYTA (voxelotor) From Worldwide Markets Read more
Lilly’s Kisunla (donanemab-azbt) Approved in Japan for the Treatment of Early Symptomatic Alzheimer’s Disease Read more